Your browser doesn't support javascript.
loading
Evaluation of Trace Elements in Augmentation of Statin-Induced Cytotoxicity in Uremic Serum-Exposed Human Rhabdomyosarcoma Cells.
Uchiyama, Hitoshi; Tsujimoto, Masayuki; Shimada, Naomi; Tsutsui, Koji; Nitta, Ayaka; Yoshida, Takuya; Furukubo, Taku; Izumi, Satoshi; Yamakawa, Tomoyuki; Tachiki, Hidehisa; Minegaki, Tetsuya; Nishiguchi, Kohshi.
Afiliación
  • Uchiyama H; Research & Development Division, Towa Pharmaceutical Co., Ltd., Kyoto Research Park KISTIC#202, 134 Chudoji Minami-Machi, Shimogyo-ku, Kyoto 600-8813, Japan. h-uchiyama@towayakuhin.co.jp.
  • Tsujimoto M; Department of Clinical Pharmacy, Faculty of Pharmaceutical Science, Kyoto Pharmaceutical University, 5 Misasagi Nakauchi-cho, Yamashina-ku, Kyoto 607-8414, Japan. tsujimt@mb.kyoto-phu.ac.jp.
  • Shimada N; Department of Clinical Pharmacy, Faculty of Pharmaceutical Science, Kyoto Pharmaceutical University, 5 Misasagi Nakauchi-cho, Yamashina-ku, Kyoto 607-8414, Japan. ky09173@poppy.kyoto-phu.ac.jp.
  • Tsutsui K; Department of Clinical Pharmacy, Faculty of Pharmaceutical Science, Kyoto Pharmaceutical University, 5 Misasagi Nakauchi-cho, Yamashina-ku, Kyoto 607-8414, Japan. ky09225@poppy.kyoto-phu.ac.jp.
  • Nitta A; Department of Clinical Pharmacy, Faculty of Pharmaceutical Science, Kyoto Pharmaceutical University, 5 Misasagi Nakauchi-cho, Yamashina-ku, Kyoto 607-8414, Japan. ky09267@poppy.kyoto-phu.ac.jp.
  • Yoshida T; Department of Clinical Pharmacy, Faculty of Pharmaceutical Science, Kyoto Pharmaceutical University, 5 Misasagi Nakauchi-cho, Yamashina-ku, Kyoto 607-8414, Japan. kd13007@poppy.kyoto-phu.ac.jp.
  • Furukubo T; Department of Pharmacy Service, Shirasagi Hospital, 7-11-23 Kumata, Higashisumiyoshi-ku, Osaka 546-0002, Japan. kd13007@poppy.kyoto-phu.ac.jp.
  • Izumi S; Department of Pharmacy Service, Shirasagi Hospital, 7-11-23 Kumata, Higashisumiyoshi-ku, Osaka 546-0002, Japan. furukubo@shirasagi-hp.or.jp.
  • Yamakawa T; Department of Pharmacy Service, Shirasagi Hospital, 7-11-23 Kumata, Higashisumiyoshi-ku, Osaka 546-0002, Japan. izumi@shirasagi-hp.or.jp.
  • Tachiki H; Department of Medicine, Shirasagi Hospital, 7-11-23 Kumata, Higashisumiyoshi-ku, Osaka 546-0002, Japan. yamakawa@shirasagi-hp.or.jp.
  • Minegaki T; Research & Development Division, Towa Pharmaceutical Co., Ltd., Kyoto Research Park KISTIC#202, 134 Chudoji Minami-Machi, Shimogyo-ku, Kyoto 600-8813, Japan. h-tachiki@towayakuhin.co.jp.
  • Nishiguchi K; Department of Clinical Pharmacy, Faculty of Pharmaceutical Science, Kyoto Pharmaceutical University, 5 Misasagi Nakauchi-cho, Yamashina-ku, Kyoto 607-8414, Japan. t-minegaki@mb.kyoto-phu.ac.jp.
Toxins (Basel) ; 10(2)2018 01 25.
Article en En | MEDLINE | ID: mdl-29370118
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Rabdomiosarcoma / Uremia / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Suero / Metales Límite: Humans Idioma: En Revista: Toxins (Basel) Año: 2018 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Rabdomiosarcoma / Uremia / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Suero / Metales Límite: Humans Idioma: En Revista: Toxins (Basel) Año: 2018 Tipo del documento: Article País de afiliación: Japón